Long-term depression in hippocampal interneurons: Joint requirement for pre- and postsynaptic events

Science

Volumn 285, Issue 5432, 1999, Pages 1411-1414

  Laezza, Fernanda ^a   Doherty, James J ^a   Dingledine, Raymond ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; GLUTAMATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; HIPPOCAMPUS; INTERNEURON; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CALCIUM; EGTAZIC ACID; ELECTRIC STIMULATION; HIPPOCAMPUS; INTERNEURONS; MALE; NEURONAL PLASTICITY; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, METABOTROPIC GLUTAMATE; SYNAPSES; SYNAPTIC TRANSMISSION; TETANY;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS; MAMMALIA;

EID: 0033609981     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.285.5432.1411     Document Type: Article

References (47)

1. M. F. Bear and W. C. Abraham, Annu. Rev. Neurosci. 19, 437 (1996); D. J. Linden and J. A. Connor, ibid. 18, 319 (1995).
2. M. F. Bear and W. C. Abraham, Annu. Rev. Neurosci. 19, 437 (1996); D. J. Linden and J. A. Connor, ibid. 18, 319 (1995).
3. T. V. Bliss and G. L. Collingridge, Nature 361, 31 (1993).
4. G. Maccaferri and C. J. McBain, Neuron 15, 135 (1995).
5. _, J. Neurosci. 16, 5334 (1996).
6. G. Maccaferri, K. Toth, C. J. McBain, Science 279, 1368 (1998).
7. M. Ouardouz and J. C. Lacaille, J. Neurophysiol. 73, 2 (1995). L. L. McMahon and J. A. Kauer [Neuron 18, 295 (1997)] described a form of LTD (iLTD) induced in some CA1 st. radiatum intemeurons after high- frequency stimulation of Schaffer collateral inputs, while the interneuron was either depolarized or in current clamp conditions in the absence of NMDA receptor blockers. Because depolarization blocks LTD in our study, the two phenomena are unlikely to be the same.
8. M. Ouardouz and J. C. Lacaille, J. Neurophysiol. 73, 2 (1995). L. L. McMahon and J. A. Kauer [Neuron 18, 295 (1997)] described a form of LTD (iLTD) induced in some CA1 st. radiatum intemeurons after high-frequency stimulation of Schaffer collateral inputs, while the interneuron was either depolarized or in current clamp conditions in the absence of NMDA receptor blockers. Because depolarization blocks LTD in our study, the two phenomena are unlikely to be the same.
9. N. Mahanty and P. Sah, Nature 394, 683 (1998).
10. J. G. Gu, C. Albuquerque, C. J. Lee, A. B. MacDermott, ibid. 381, 793 (1996).
11. K. Toth and C. J. McBain, Nature Neurosci. 1, 572 (1998).
12. 2+ permeable than those having GluR2 [M. Hollman, M. Hartley, S. Heinemann, Science 252, 851 (1991)].
13. M. S. Washburn, M. Numberger, S. Zhang, R. Dingledine, J. Neurosci. 17, 9393 (1997).
14. M. Iino, S. Mochizuki, S. Ozawa, Neurosci. Lett. 173, 14 (1994).
15. 4 spermine (60 μM), and 0.4% biocytin. When indicated, 10 or 30 mM BAPTA was added to the internal solution. Stimulating electrodes (patch pipettes filled with artificial cerebrospinal fluid (ACSF) or monopolar platinum iridium electrodes) were positioned in the CA3 pyramidal cell layer. Electrical stimuli (10 to 100 μA) were delivered every 3 or 6 s. Synaptic responses were filtered at 3 kHz and digitized at 30 kHz. Input and series resistances were monitored periodically; only cells with stable series and input resistances were used for the study. All drugs were dissolved in known quantities of ACSF and delivered through the bath perfusion system. After recording, all slices containing biocytin-filled interneurons were retained for morphological identification of the recorded neuron as described (31).
16. C. McBain and R. Dingledine, J. Physiol. 462, 373 (1993).
17. Rectification was quantified by measuring the ratio of EPSC chord conductances at +40 mV and -70 mV (the rectification ratio, r.r.). EPSCs with r.r. > 0.6 were considered type I, whereas those exhibiting inwardly rectifying EPSCs with r.r. < 0.5 were classified as type II.
18. D. Bleakman et al., Neuropharmacology 35, 1689 (1996).
19. R. A. Zalutsky and R. A. Nicoll, Science 248, 1619 (1990).
20. Transient potentiation was observed 10 min after tetanus in 7 of 10 type I responses. However potentiation subsided in three out of the four neurons that were followed for at least 20 min after tetanus (paired comparisons, P > 0.05).
21. H. Jackson and P. N. Usherwood, Trends Neurosci. 11, 278 (1988); M. Blaschke et al., Proc. Natl. Acad. Sci. U.S.A. 90, 6528 (1993); S. Herlitze et al., Neuron 10, 1131 (1993); T. Isa, M. Iino, S. Ozawa. Neuroreport 7, 689 (1996); M. S. Washbum and R. Dingledine, J. Pharmacol. Exp. Ther. 278, 669 (1996); Z. F. Mainen, Z. Jia, J. Roder, R. Malinow, Nature Neurosci. 1, 579 (1998).
22. H. Jackson and P. N. Usherwood, Trends Neurosci. 11, 278 (1988); M. Blaschke et al., Proc. Natl. Acad. Sci. U.S.A. 90, 6528 (1993); S. Herlitze et al., Neuron 10, 1131 (1993); T. Isa, M. Iino, S. Ozawa. Neuroreport 7, 689 (1996); M. S. Washbum and R. Dingledine, J. Pharmacol. Exp. Ther. 278, 669 (1996); Z. F. Mainen, Z. Jia, J. Roder, R. Malinow, Nature Neurosci. 1, 579 (1998).
23. H. Jackson and P. N. Usherwood, Trends Neurosci. 11, 278 (1988); M. Blaschke et al., Proc. Natl. Acad. Sci. U.S.A. 90, 6528 (1993); S. Herlitze et al., Neuron 10, 1131 (1993); T. Isa, M. Iino, S. Ozawa. Neuroreport 7, 689 (1996); M. S. Washbum and R. Dingledine, J. Pharmacol. Exp. Ther. 278, 669 (1996); Z. F. Mainen, Z. Jia, J. Roder, R. Malinow, Nature Neurosci. 1, 579 (1998).
24. H. Jackson and P. N. Usherwood, Trends Neurosci. 11, 278 (1988); M. Blaschke et al., Proc. Natl. Acad. Sci. U.S.A. 90, 6528 (1993); S. Herlitze et al., Neuron 10, 1131 (1993); T. Isa, M. Iino, S. Ozawa. Neuroreport 7, 689 (1996); M. S. Washbum and R. Dingledine, J. Pharmacol. Exp. Ther. 278, 669 (1996); Z. F. Mainen, Z. Jia, J. Roder, R. Malinow, Nature Neurosci. 1, 579 (1998).
25. H. Jackson and P. N. Usherwood, Trends Neurosci. 11, 278 (1988); M. Blaschke et al., Proc. Natl. Acad. Sci. U.S.A. 90, 6528 (1993); S. Herlitze et al., Neuron 10, 1131 (1993); T. Isa, M. Iino, S. Ozawa. Neuroreport 7, 689 (1996); M. S. Washbum and R. Dingledine, J. Pharmacol. Exp. Ther. 278, 669 (1996); Z. F. Mainen, Z. Jia, J. Roder, R. Malinow, Nature Neurosci. 1, 579 (1998).
26. H. Jackson and P. N. Usherwood, Trends Neurosci. 11, 278 (1988); M. Blaschke et al., Proc. Natl. Acad. Sci. U.S.A. 90, 6528 (1993); S. Herlitze et al., Neuron 10, 1131 (1993); T. Isa, M. Iino, S. Ozawa. Neuroreport 7, 689 (1996); M. S. Washbum and R. Dingledine, J. Pharmacol. Exp. Ther. 278, 669 (1996); Z. F. Mainen, Z. Jia, J. Roder, R. Malinow, Nature Neurosci. 1, 579 (1998).
27. I. Llano, N. Leresche, A. Marty, Neuron 6, 565 (1991); M. F. Yeckel, A. Kapur, D. Johnston, Nature Neurosci. 2, 625 (1999).
28. I. Llano, N. Leresche, A. Marty, Neuron 6, 565 (1991); M. F. Yeckel, A. Kapur, D. Johnston, Nature Neurosci. 2, 625 (1999).
29. 2+ channels may contribute to LTD as reported for the dentate gyrus (32).
30. R. C. Malenka and R. A. Nicoll, Neuron 19, 473 (1997); R. C. Carroll et al., Nature Neurosci. 2, 454 (1999); D. V. Lissin et al., J. Neurosci. 19, 1263 (1999).
31. R. C. Malenka and R. A. Nicoll, Neuron 19, 473 (1997); R. C. Carroll et al., Nature Neurosci. 2, 454 (1999); D. V. Lissin et al., J. Neurosci. 19, 1263 (1999).
32. R. C. Malenka and R. A. Nicoll, Neuron 19, 473 (1997); R. C. Carroll et al., Nature Neurosci. 2, 454 (1999); D. V. Lissin et al., J. Neurosci. 19, 1263 (1999).
33. T. Phillips, A. Makoff, S. Brown, S. Rees, P. Emson, NeuroReport 8, 3349 (1997).
34. R. Shigemoto et al., J. Neurosci. 17, 7503 (1997).
35. S. R. Bradley, A. I. Levey, S. M. Hersch, P. J. Conn, ibid. 16, 2044 (1996); J. A. Saugstad, J. M. Kinzie, E. R. Mulvihill, T. P Sergeson, G. L. Westbrook, Mol. Pharmacol. 45, 367 (1994).
36. S. R. Bradley, A. I. Levey, S. M. Hersch, P. J. Conn, ibid. 16, 2044 (1996); J. A. Saugstad, J. M. Kinzie, E. R. Mulvihill, T. P Sergeson, G. L. Westbrook, Mol. Pharmacol. 45, 367 (1994).
37. We analyzed 65 thin sections through the hippocampus that had been processed for mGluR7 mRNA in situ hybridization. We found no significant clusters of silver grains localized in the CA3 st. radiatum, suggesting that the mRNA for mGluR7 was absent in CA3 st. radiatum interneurons. In contrast, CA3 pyramidal neurons, dentate granule cells, and some hilar neurons were intensely labeled.
38. P. J. Conn and J.-P. Pin, Annu. Rev. Pharmacol. Toxicol. 37, 205 (1997).
39. A. E. Kingston et al., Neuropharmacology 37, 1 (1998).
40. P. J. Conn, personal communication.
41. L. Huang, M. J. Rowan, R. Anwyl, NeuroReport 8, 687 (1997); T. Tzounopoulos, R. Janz, T. C. Sudhof, R. A. Nicoll, R. C. Malenka, Neuron 21, 837 (1998); M. Yoki et al., Science 273, 645 (1996).
42. L. Huang, M. J. Rowan, R. Anwyl, NeuroReport 8, 687 (1997); T. Tzounopoulos, R. Janz, T. C. Sudhof, R. A. Nicoll, R. C. Malenka, Neuron 21, 837 (1998); M. Yoki et al., Science 273, 645 (1996).
43. L. Huang, M. J. Rowan, R. Anwyl, NeuroReport 8, 687 (1997); T. Tzounopoulos, R. Janz, T. C. Sudhof, R. A. Nicoll, R. C. Malenka, Neuron 21, 837 (1998); M. Yoki et al., Science 273, 645 (1996).
44. J. J. Doherty and R. Dingledine, J. Neurophysiol. 77, 393 (1997).
45. Y. Wang, M. J. Rowan, R. Anwyl, J. Neurophysiol. 77, 812 (1997).
46. I. Vida, K. Halasy, C. Szinyei, P. Somogyi, E. H. Buhl, J. Physiol. 506, 755 (1998).
47. Supported by the NIH (R.D.), the American Epilepsy Society (J.D.), and Sigma XI (F.L). We thank R. Calabrese and D. Jaeger for Neurolucida software, S. F. Traynelis for npm52 software, D. Leander for LY303070, D. Schoepp and J. Conn for LY341495, and A. Young for brain sections hybridized in situ for mGluR7 mRNA. We thank J. Conn, D. Mott, S. Traynelis, C McBain, and G. Maccaferri for useful comments on the manuscript.